Oyvind-Fylling-Jensen, DVM, PhD, Joins MariCal Board of Directors
Date: August 17, 2006
MARICAL CORPORATE ANNOUNCEMENT
Portland, Maine USA; August 17, 2006 --- Steven Morrell, MariCal's Board Chairman and Partner of Teknoinvest AS, confirmed the joining of Dr. Øyvind Fylling-Jensen to MariCal's Board of Directors at the Company's recent quarterly board meeting on Thursday, August 10, 2006.
Mr. Morrell expressed," having someone of Øyvind Fylling-Jensen's management calibre and global stature from the biotechnology and aquaculture industry is not only a strong addition to the MariCal board but also validation that MariCal's calcium receptor technology has broad industry application." MariCal's SuperSmolt® Program is the commercial salmon industry application of their calcium receptor technology designed for the seawater pre-adaptation of anadromous fish, or smoltification, while remaining in a freshwater environment - resulting in significant production efficiencies, improving profitability and reducing costs.
Dr. Fylling-Jensen is currently the CEO of the Norwegian Food Research Institute - Matforsk AS. He holds a degree in veterinary medicine from the University of Giessen in Germany and a PhD in veterinary pathology from the Norwegian Veterinary College. Dr. Fylling-Jensen is an experienced business person with a broad industrial background in biotechnology, diagnostics, pharmacology and aquaculture. He has had leading positions in companies like Dynal, AS MedLab and Alpharma-Fine Chemicals Division. Prior to joining Matforsk he was executive vice president of Fjord Seafood ASA, responsible for their fish farming activities.
Commenting on the attraction to join MariCal, Dr. Fylling-Jensen stated, "I am honoured by the opportunity to serve on the Board of MariCal, contributing to the continuous development of an exiting technology. The Company has a strong intellectual property position and I see several future developments that can enhance MariCal's market position in the future."
The joining of Dr. Fylling-Jensen follows the recent announcement by MariCal's CEO and co-founder, Dr. H. William Harris, Ph.D., M.D. on 10 Aug of the Company's raising of over $3.1MM in investment commitment provided by US and Norwegian investors to fuel research & development and job growth in Southern Maine.
